Table 2.
Therapeutic Scheme of 98 Mediastinal Lymph Node-Negative Patients With Small Cell Lung Cancer (SCLC)
| Clinical Data | All | TNM I | TNM II | p Value |
|---|---|---|---|---|
| Chemotherapy | 0.071 | |||
| EP | 33 (33.67%) | 12 (12.25%) | 21 (21.43%) | |
| CE | 28 (28.58%) | 10 (10.20%) | 18 (18.37%) | |
| CE plus PTX | 6 (6.12%) | 2 (2.02%) | 4 (4.1%) | |
| No chemotherapy | 31 (31.63%) | 10 (10.20%) | 21 (21.43%) | |
| Prophylactic cranial irradiation | 0.070 | |||
| Yes | 27 (27.55%) | 11 (11.22%) | 16 (16.33%) | |
| No | 71 (72.45%) | 23 (23.47%) | 48 (48.98%) | |
| Surgery procedure | 0.062 | |||
| Sublobar resection | 8 (8.16%) | 8 (8.16%) | 0 (0%) | |
| Lobectomy | 41 (41.84%) | 13 (13.27%) | 28 (28.57%) | |
| Pneumonectomy | 49 (50.00%) | 13 (13.27%) | 36 (36.73%) |